Mumbai, Feb
09: Pharma major Lupin announced the launch of its Clonidine Hydrochloride extended-release tablets, 0.1mg,
having received an approval from the United States Food and Drug Administration (FDA) earlier.
Lupin's Clonidine Hydrochloride ER tablets is the generic
equivalent of Concordia International Corp's Kapvay tablets. It is
indicated for the treatment of attention deficit hyperactivity disorder
(ADHD) as monotherapy or as adjunctive therapy to stimulant
medications.
Kapvay tablets had annual sales of approximately USD 66 million in the US (IQVIA MAT December 2017). UNI
Kapvay tablets had annual sales of approximately USD 66 million in the US (IQVIA MAT December 2017). UNI
Post A Comment:
0 comments so far,add yours